MedPath

The effect of Myo-inositol on the treatment of male infertility in couples under IUI

Phase 3
Conditions
Male infertility due to oligoastenospermia.
Male infertility
Registration Number
IRCT20181031041519N1
Lead Sponsor
Iran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
60
Inclusion Criteria

Couples who have not been pregnant for one year
In the studies included hysterosalpingography and hormonal testing all women were uncomplicated
Men have oligo or asthenospermia.

Exclusion Criteria

Sever male factor (Oligo Stoenou men)
Untreated hormonal problem
BMI higher than 35
The age of a woman is over 38 years old

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Sperm motility Morphology Agglutination Volume Acidity Duration of liquefaction Dfi. Timepoint: sperm sample day After sample incubation Two hours after treatment with myo-inositol. Method of measurement: Examination of sperm samples under a microscope.
Secondary Outcome Measures
NameTimeMethod
Fertility. Timepoint: Two weeks after iui. Method of measurement: Serum Beta HCG.
© Copyright 2025. All Rights Reserved by MedPath